abstract |
The present invention provides an administration method for treating a TNFα-related disorder such as Crohn's disease in which TNFα activity is harmful. Administering at least one induction dose of a TNFα inhibitor to a subject in need thereof, such that a threshold level of the TNFα inhibitor is obtained within the induction phase, followed by a TNFα inhibitor; A multiple variable dosage method for treating a disorder in which TNFα activity is detrimental comprising administering to said subject within the treatment phase at least one therapeutic dose of: [Selection figure] None |